218 related articles for article (PubMed ID: 31588710)
41. Synthesis of novel chiral TBBt derivatives with hydroxyl moiety. Studies on inhibition of human protein kinase CK2α and cytotoxicity properties.
Borowiecki P; Wawro AM; Wińska P; Wielechowska M; Bretner M
Eur J Med Chem; 2014 Sep; 84():364-74. PubMed ID: 25036794
[TBL] [Abstract][Full Text] [Related]
42. Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.
Cozza G; Sarno S; Ruzzene M; Girardi C; Orzeszko A; Kazimierczuk Z; Zagotto G; Bonaiuto E; Di Paolo ML; Pinna LA
Biochim Biophys Acta; 2013 Jul; 1834(7):1402-9. PubMed ID: 23360763
[TBL] [Abstract][Full Text] [Related]
43. Ethyl 2-(benzylidene)-7-methyl-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-6-carboxylate analogues as a new scaffold for protein kinase casein kinase 2 inhibitor.
Jin CH; Jun KY; Lee E; Kim S; Kwon Y; Kim K; Na Y
Bioorg Med Chem; 2014 Sep; 22(17):4553-65. PubMed ID: 25131958
[TBL] [Abstract][Full Text] [Related]
44. Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells.
Pierre F; Regan CF; Chevrel MC; Siddiqui-Jain A; Macalino D; Streiner N; Drygin D; Haddach M; O'Brien SE; Rice WG; Ryckman DM
Bioorg Med Chem Lett; 2012 May; 22(9):3327-31. PubMed ID: 22460033
[TBL] [Abstract][Full Text] [Related]
45. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
Gyenis L; Turowec JP; Bretner M; Litchfield DW
Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
[TBL] [Abstract][Full Text] [Related]
46. A critical role for CK2 in cytokine-induced activation of NFκB in pancreatic β cell death.
Jaksch C; Thams P
Endocrine; 2014 Sep; 47(1):117-28. PubMed ID: 24366643
[TBL] [Abstract][Full Text] [Related]
47. Regulation of TMEM16A by CK2 and Its Role in Cellular Proliferation.
Pinto MC; Schreiber R; Lerias J; Ousingsawat J; Duarte A; Amaral M; Kunzelmann K
Cells; 2020 May; 9(5):. PubMed ID: 32380794
[TBL] [Abstract][Full Text] [Related]
48. Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2.
Liu S; Hsieh D; Yang YL; Xu Z; Peto C; Jablons DM; You L
BMC Pharmacol Toxicol; 2013 Jul; 14():36. PubMed ID: 23845105
[TBL] [Abstract][Full Text] [Related]
49. Protein kinase CK2 is involved in zinc homeostasis in breast and prostate cancer cells.
Zaman MS; Johnson AJ; Petersingham G; Muench GW; Dong Q; Wu MJ
Biometals; 2019 Dec; 32(6):861-873. PubMed ID: 31583500
[TBL] [Abstract][Full Text] [Related]
50. Constitutive activation of casein kinase 2 in glioblastomas: Absence of class restriction and broad therapeutic potential.
Dubois N; Willems M; Nguyen-Khac MT; Kroonen J; Goffart N; Deprez M; Bours V; Robe PA
Int J Oncol; 2016 Jun; 48(6):2445-52. PubMed ID: 27098015
[TBL] [Abstract][Full Text] [Related]
51. Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.
Trembley JH; Unger GM; Gomez OC; Abedin J; Korman VL; Vogel RI; Niehans G; Kren BT; Ahmed K
Mol Cell Pharmacol; 2014; 6(2):15-25. PubMed ID: 25893034
[TBL] [Abstract][Full Text] [Related]
52. Up-Regulation of the Alpha Prime Subunit of Protein Kinase CK2 as a Marker of Fast Proliferation in GL261 Cultured Cells.
Villamañan L; Alcaraz E; Pinna LA; Ruzzene M; Itarte E; Arús C; Plana M; Candiota AP
Pathol Oncol Res; 2019 Oct; 25(4):1659-1663. PubMed ID: 30607803
[TBL] [Abstract][Full Text] [Related]
53. Downregulation of protein kinase CK2 induces autophagic cell death through modulation of the mTOR and MAPK signaling pathways in human glioblastoma cells.
Olsen BB; Svenstrup TH; Guerra B
Int J Oncol; 2012 Dec; 41(6):1967-76. PubMed ID: 23007634
[TBL] [Abstract][Full Text] [Related]
54. Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole.
Battistutta R; Mazzorana M; Sarno S; Kazimierczuk Z; Zanotti G; Pinna LA
Chem Biol; 2005 Nov; 12(11):1211-9. PubMed ID: 16298300
[TBL] [Abstract][Full Text] [Related]
55. Structure-based design of novel potent protein kinase CK2 (CK2) inhibitors with phenyl-azole scaffolds.
Hou Z; Nakanishi I; Kinoshita T; Takei Y; Yasue M; Misu R; Suzuki Y; Nakamura S; Kure T; Ohno H; Murata K; Kitaura K; Hirasawa A; Tsujimoto G; Oishi S; Fujii N
J Med Chem; 2012 Mar; 55(6):2899-903. PubMed ID: 22339433
[TBL] [Abstract][Full Text] [Related]
56. Protein kinase CK2 promotes cancer cell viability via up-regulation of cyclooxygenase-2 expression and enhanced prostaglandin E2 production.
Yefi R; Ponce DP; Niechi I; Silva E; Cabello P; Rodriguez DA; Marcelain K; Armisen R; Quest AF; Tapia JC
J Cell Biochem; 2011 Nov; 112(11):3167-75. PubMed ID: 21732411
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, biological properties and structural study of new halogenated azolo[4,5-b]pyridines as inhibitors of CK2 kinase.
Chojnacki K; Lindenblatt D; Wińska P; Wielechowska M; Toelzer C; Niefind K; Bretner M
Bioorg Chem; 2021 Jan; 106():104502. PubMed ID: 33317841
[TBL] [Abstract][Full Text] [Related]
58. Casein kinase 2 inhibition attenuates androgen receptor function and cell proliferation in prostate cancer cells.
Yao K; Youn H; Gao X; Huang B; Zhou F; Li B; Han H
Prostate; 2012 Sep; 72(13):1423-30. PubMed ID: 22290244
[TBL] [Abstract][Full Text] [Related]
59. Effects of CK2 inhibition in cultured fibroblasts from Type 1 Diabetic patients with or without nephropathy.
Iori E; Ruzzene M; Zanin S; Sbrignadello S; Pinna LA; Tessari P
Growth Factors; 2015; 33(4):259-66. PubMed ID: 26340273
[TBL] [Abstract][Full Text] [Related]
60. Major tegument protein VP8 of bovine herpesvirus 1 is phosphorylated by viral US3 and cellular CK2 protein kinases.
Labiuk SL; Babiuk LA; van Drunen Littel-van den Hurk S
J Gen Virol; 2009 Dec; 90(Pt 12):2829-2839. PubMed ID: 19692545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
